InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Sharp Shalini, Director. Director active across 1 companies, notably Mirati Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. The latest transaction was filed on 14 January 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations2 total
02,546 shares0
Common Stock
SEC:0001214659-22-000841·
02,546 shares0
Common Stock
SEC:0001214659-22-000841:0·
2 of 2 declarations
About Sharp Shalini
Shalini Sharp serves as a Board Member at Mirati Therapeutics, Inc. She brings her expertise in corporate governance and strategy to the board. Shalini plays a key role in strategic decision-making and the future direction of the company, thereby contributing to its success in the biopharmaceutical sector.
